UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 383

Sortiert nach

Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines

Amyloid, 2016-10, Vol.23 (4), p.209-213

2016

Link zum Volltext

Verfügbarkeit prüfen

A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells

Nature communications, 2021-05, Vol.12 (1), p.3142-3142, Article 3142

2021

Link zum Volltext

Verfügbarkeit prüfen

Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis

Amyloid, 2014-12, Vol.21 (4), p.221-224

2014

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor

PloS one, 2008-08, Vol.3 (8), p.e2899-e2899

2008

Link zum Volltext

Verfügbarkeit prüfen

Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis

Scientific reports, 2016-05, Vol.6 (1), p.26623, Article 26623

2016

Link zum Volltext

Verfügbarkeit prüfen

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2020-10, Vol.27 (4), p.217-222

2020

Link zum Volltext

Verfügbarkeit prüfen

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2018-10, Vol.25 (4), p.215-219

2018

Link zum Volltext

Verfügbarkeit prüfen

Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils

PloS one, 2012-09, Vol.7 (9), p.e44992

2012

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin enhances nerve regeneration

Journal of neurochemistry, 2007-10, Vol.103 (2), p.831-839

2007

Link zum Volltext

Verfügbarkeit prüfen

Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein

Proceedings of the National Academy of Sciences - PNAS, 2011-04, Vol.108 (14), p.5584-5589

2011

Link zum Volltext

Verfügbarkeit prüfen

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

Amyloid, 2022-10, Vol.29 (4), p.213-219

2022

Link zum Volltext

Verfügbarkeit prüfen

Polymer-doxycycline conjugates as fibril disrupters: An approach towards the treatment of a rare amyloidotic disease

Journal of controlled release, 2015-01, Vol.198, p.80-90

2015

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin Internalization by Sensory Neurons Is Megalin Mediated and Necessary for Its Neuritogenic Activity

The Journal of neuroscience, 2009-03, Vol.29 (10), p.3220-3232

2009

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin is a metallopeptidase with an inducible active site

Biochemical journal, 2012-05, Vol.443 (3), p.769-778

2012

Link zum Volltext

Verfügbarkeit prüfen

Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis

Amyloid, 2005-03, Vol.12 (1), p.1-4

2005

Link zum Volltext

Verfügbarkeit prüfen

Lead optimization of resilient next-generation transthyretin stabilizers for multiple target-product profiles: approaching the CNS

Amyloid, 2019-03, Vol.26 (sup1), p.77-78

2019

Link zum Volltext

Verfügbarkeit prüfen

BDNF gene delivery mediated by neuron-targeted nanoparticles is neuroprotective in peripheral nerve injury

Biomaterials, 2017-03, Vol.121, p.83-96

2017

Link zum Volltext

Verfügbarkeit prüfen

Selective recognition of human small transthyretin aggregates by a novel monoclonal antibody

Amyloid, 2023-01, Vol.30 (1), p.74-80

2023

Link zum Volltext

Verfügbarkeit prüfen

Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis

Amyloid, 2012-12, Vol.19 (4), p.167-170

2012

Link zum Volltext

Verfügbarkeit prüfen

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

Amyloid, 2010-09, Vol.17 (3-4), p.101-104

2010

Link zum Volltext

Verfügbarkeit prüfen

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

Amyloid, 2012-06, Vol.19 (S1), p.34-36

2012

Link zum Volltext

Verfügbarkeit prüfen

Delivery of an anti‐transthyretin Nanobody to the brain through intranasal administration reveals transthyretin expression and secretion by motor neurons

Journal of neurochemistry, 2018-06, Vol.145 (5), p.393-408

2018

Link zum Volltext

Verfügbarkeit prüfen

Wildfire effects on two freshwater producers: Combining in-situ and laboratory bioassays

Ecotoxicology and environmental safety, 2020-05, Vol.194, p.110361, Article 110361

2020

Link zum Volltext

Verfügbarkeit prüfen

Structural basis for the protective role of sulfite against transthyretin amyloid formation

Biochimica et biophysica acta, 2007, Vol.1774 (1), p.59-64

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 383

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(355)
Mit Volltextzugriff
(350)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Amyloid
(33)
The Journal Of Biological Chemistry
(11)
Plos One
(8)
Human Genetics
(7)
Arquivos Brasileiros De Cardiologia
(6)
Food Research International
(6)
Human Mutation
(6)
The Journal Of Neuroscience
(6)
Biochemical Journal
(5)
Scientific Reports
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines

A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells

Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis

Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor

Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis

Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils

Transthyretin enhances nerve regeneration

Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

Polymer-doxycycline conjugates as fibril disrupters: An approach towards the treatment of a rare amyloidotic disease

Transthyretin Internalization by Sensory Neurons Is Megalin Mediated and Necessary for Its Neuritogenic Activity

Transthyretin is a metallopeptidase with an inducible active site

Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis

Lead optimization of resilient next-generation transthyretin stabilizers for multiple target-product profiles: approaching the CNS

BDNF gene delivery mediated by neuron-targeted nanoparticles is neuroprotective in peripheral nerve injury

Selective recognition of human small transthyretin aggregates by a novel monoclonal antibody

Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

Delivery of an anti‐transthyretin Nanobody to the brain through intranasal administration reveals transthyretin expression and secretion by motor neurons

Wildfire effects on two freshwater producers: Combining in-situ and laboratory bioassays

Structural basis for the protective role of sulfite against transthyretin amyloid formation

Suchergebnisse filtern